Sight Sciences, Inc. Common Stock (SGHT) Stock Price

SGHTStock

$8.32+98.11%52W

Market Cap$458.33M

P/E—

PEG Ratio—

Div yield—

Beta2.48

SGHT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)48.07%

Price vs S&P 500 (4W)55.06%

VGM Score61.51

Book Value / Share (Quarterly)$0.97

P/TBV (Annual)0.94x

Indicated Dividend (Annual)$0.00

Revenue Growth (3Y)2.74%

Cash Flow / Share (Quarterly)$-0.43

Price vs S&P 500 (YTD)-6.28%

Gross Margin (TTM)88.44%

Net Profit Margin (TTM)-35.69%

EPS (TTM)$-0.56

10-Day Avg Trading Volume0.32M

EPS Excl Extra (TTM)$-0.56

Revenue Growth (5Y)22.86%

EPS (Annual)$-0.74

ROI (Annual)-36.86%

Gross Margin (Annual)86.95%

Net Profit Margin (5Y Avg)-86.44%

Cash / Share (Quarterly)$1.46

Revenue Growth QoQ (YoY)19.55%

ROA (Last FY)-33.33%

Revenue Growth TTM (YoY)9.27%

EBITD / Share (TTM)$-0.51

ROE (5Y Avg)-49.23%

Operating Margin (TTM)-33.43%

Cash Flow / Share (Annual)$-0.56

P/B Ratio8.67x

P/B Ratio (Quarterly)5.58x

Net Income / Employee (Annual)$-206,600

EV / Revenue (TTM)5.03x

Net Interest Coverage (TTM)-31.86x

ROA (TTM)-26.68%

EPS Incl Extra (Annual)$-0.74

Current Ratio (Annual)10.22x

Quick Ratio (Quarterly)4.45x

3-Month Avg Trading Volume0.25M

52-Week Price Return98.11%

Revenue / Employee (TTM)$448,300

Tangible BV / Share (Quarterly)$2.61

P/S Ratio (Annual)5.92x

Asset Turnover (Annual)0.67x

52-Week High$9.24

Operating Margin (5Y Avg)-81.44%

EPS Excl Extra (Annual)$-0.74

CapEx CAGR (5Y)-25.10%

26-Week Price Return59.32%

Quick Ratio (Annual)9.22x

13-Week Price Return63.03%

Total Debt / Equity (Annual)0.63x

Current Ratio (Quarterly)4.95x

Enterprise Value$419.36M

Revenue / Share Growth (5Y)19.32%

Asset Turnover (TTM)0.75x

Revenue / Employee (Annual)$415,900

Inventory Turnover (Annual)1.43x

Pretax Margin (Annual)-49.66%

Cash / Share (Annual)$1.72

3-Month Return Std Dev75.28%

Gross Margin (5Y Avg)84.57%

Net Income / Employee (TTM)$-160,000

ROE (Last FY)-60.10%

Net Interest Coverage (Annual)-14.39x

EPS Basic Excl Extra (Annual)$-0.74

Receivables Turnover (TTM)7.94x

Total Debt / Equity (Quarterly)0.77x

EPS Incl Extra (TTM)$-0.56

Receivables Turnover (Annual)7.54x

ROI (TTM)-30.00%

P/S Ratio (TTM)5.50x

Pretax Margin (5Y Avg)-86.26%

Revenue / Share (Annual)$1.48

Tangible BV / Share (Annual)$3.31

Price vs S&P 500 (52W)79.80%

Year-to-Date Return5.67%

5-Day Price Return1.95%

EPS Normalized (Annual)$-0.74

ROA (5Y Avg)-33.13%

Net Profit Margin (Annual)-49.67%

Month-to-Date Return59.32%

Cash Flow / Share (TTM)$-1.26

EBITD / Share (Annual)$-0.70

Operating Margin (Annual)-47.95%

LT Debt / Equity (Annual)0.63x

ROI (5Y Avg)-36.37%

LT Debt / Equity (Quarterly)0.58x

EPS Basic Excl Extra (TTM)$-0.56

P/TBV (Quarterly)1.19x

P/B Ratio (Annual)6.56x

Inventory Turnover (TTM)1.62x

Pretax Margin (TTM)-35.73%

Book Value / Share (Annual)$1.20

Price vs S&P 500 (13W)60.24%

Beta2.48x

Revenue / Share (TTM)$1.53

ROE (TTM)-50.64%

52-Week Low$3.19

vGradeD

gGradeB

mGradeA

vgmGradeB

SGHT Earnings Surprise History

Q2 25-0.23est. -0.28

Q3 25-0.16est. -0.26

Q4 25-0.08est. -0.14

Q1 26-0.24est. -0.20

Q2 26-0.08est. -0.14

SGHT Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

4.00

Industry Peers — Surgical & Medical Instruments(140)

Symbol	Value Score	Growth Score	Momentum Score	Price
SGHTSight Sciences, Inc. Common Stock	D	B	A	$8.32
SYKStryker Corporation	C	B	C	$330.59
MMM3M Company	C	D	B	$179.37
BSXBoston Scientific Corp.	C	B	D	$49.86
BDXBecton, Dickinson and Co.	B	D	B	$189.78
MDLNMedline Inc. Class A common stock	C	D	C	$35.64
RMDResMed Inc.	C	B	C	$236.59
DXCMDexCom, Inc.	D	B	B	$89.16
WSTWest Pharmaceutical Services, Inc.	D	C	B	$348.48
SOLVSolventum Corporation	C	C	B	$91.61
BAXBaxter International Inc.	B	D	B	$26.29
PENPenumbra, Inc.	D	C	C	$324.37
GMEDGLOBUS MEDICAL INC	B	B	C	$82.96
GKOSGlaukos Corporation	F	A	A	$181.39
PODDInsulet Corporation	C	A	D	$143.05
STVNStevanato Group S.p.A.	D	C	B	$22.70
TFXTeleflex Incorporated	B	F	B	$140.18
MMSIMerit Medical Systems Inc	C	B	B	$91.09
MMEDMiniMed Group, Inc. Common Stock	—	—	A	$18.92
HAEHaemonetics Corporation	C	C	A	$108.32
ICUIICU Medical Inc	C	D	B	$182.24
HTFLHeartflow, Inc. Common Stock	—	A	A	$49.89
IRTCiRhythm Holdings, Inc. Common Stock	F	A	C	$123.09
PLSEPulse Biosciences, Inc Common Stock (DE)	F	—	A	$49.00
ATRCAtriCure, Inc.	D	B	A	$48.68
UFPTUFP Technologies Inc	C	B	B	$304.21
NVCRNovoCure Limited Ordinary Shares	D	C	C	$17.62
LMATLeMaitre Vascular, Inc.	C	B	D	$78.97
INSPInspire Medical Systems, Inc.	B	B	B	$61.07
KMTSKestra Medical Technologies, Ltd. Common Stock	F	A	B	$26.92
TNDMTandem Diabetes Care, Inc.	D	C	B	$21.58
ATECAlphatec Holdings, Inc.	D	B	C	$9.33
DRTSAlpha Tau Medical Ltd. Ordinary Shares	—	—	A	$14.70
IARTIntegra LifeSciences Holdings	B	D	C	$16.79
AORTArtivion, Inc.	C	C	C	$26.38
PRCTPROCEPT BioRobotics Corporation Common Stock	C	A	D	$21.60
IRMDiRadimed Corporation	D	B	C	$87.87
BVSBioventus Inc. Class A Common Stock	B	C	A	$14.08
SGPSpyGlass Pharma, Inc. Common Stock	—	—	B	$26.60
SIBNSI-BONE, Inc. Common Stock	D	B	B	$19.54
BBNXBeta Bionics, Inc. Common Stock	D	A	A	$19.34
SSIISS Innovations International Inc. Common Stock	F	A	D	$3.55
ANGOAngioDynamics, Inc.	C	D	B	$15.95
KIDSOrthoPediatrics Corp. Common Stock	C	B	B	$24.50
MDXGMiMedx Group, Inc	C	D	C	$4.34
DCTHDelcath Systems Inc	D	B	A	$16.92
BWAYBrainsway Ltd. American Depositary Shares	F	A	C	$14.43
CERSCerus Corp	D	C	B	$2.72
TCMDTactile Systems Technology, Inc.	B	B	C	$23.58
CLPTClearPoint Neuro, Inc. Common Stock	F	A	B	$16.96
NPCENeuropace, Inc. Common Stock	D	C	C	$14.16

About Sight Sciences, Inc. Common Stock

Sight Sciences develops surgical and nonsurgical medical devices for treating eye diseases. The company's lead product, the OMNI Surgical System, treats primary open-angle glaucoma through minimally invasive canaloplasty and trabeculotomy using a single corneal incision. The company also markets the TearCare System for dry eye treatment, with glaucoma products generating the majority of revenue.